§ 4621. Definitions
Except as otherwise specified, for the purposes of this subchapter:
(1) “Department” means the Department of Health.
(2) “Evidence-based” means based on criteria and guidelines that reflect high-quality, cost-effective care. The methodology used to determine such guidelines shall meet recognized standards for systematic evaluation of all available research and shall be free from conflicts of interest. Consideration of the best available scientific evidence does not preclude consideration of experimental or investigational treatment or services under a clinical investigation approved by an institutional review board. (Added 2007, No. 80, § 14; amended 2009, No. 156 (Adj. Sess.), § I.21.)
Structure Vermont Statutes
Chapter 91 - Prescription Drug Cost Containment
§ 4605. Alternative drug or biological product selection
§ 4622. Evidence-based education program
§ 4631. Confidentiality of prescription information
§ 4631a. Expenditures by manufacturers of prescribed products
§ 4632. Disclosure of allowable expenditures and gifts by manufacturers of prescribed products
§ 4633. Pharmaceutical marketer price disclosure
§ 4634. Prescription drug price disclosure
§ 4635. Prescription drug cost transparency
§ 4636. Impact of prescription drug costs on health insurance premiums; report
§ 4637. Notice of introduction of new high-cost prescription drugs
§ 4651. Wholesale importation program for prescription drugs; design
§ 4652. Monitoring for anticompetitive behavior